How To Do Post Cycle Therapy Right After TRT or a Cycle

So you're on TRT or you did a cycle, you're wondering how you can safely come off. Cold turkey is probably not the route to go, and once you understand what exogenous testosterone actually does to the signalling chain above your testicles, the reason becomes obvious.

Start with the whole system, because the protocol only makes sense if you can see the loop it is trying to restart.

Your hypothalamus, sitting at the base of your brain, releases pulses of something called GnRH, gonadotropin releasing hormone, which is the timing signal for the whole thing. Those pulses hit your pituitary, and the pituitary answers by releasing two hormones into your blood, LH and FSH.

LH travels down to the Leydig cells in your testicles and tells them to make testosterone. FSH works on the Sertoli cells and drives sperm production. Both of those jobs depend on the local concentration of testosterone inside the testicle, which normally runs somewhere around a hundred times higher than what shows up in a blood test.

The loop closes because testosterone, and the estradiol your body makes from testosterone through the aromatase enzyme, both travel back up to the hypothalamus and pituitary and slow the pulses down. High levels in the blood mean fewer pulses, while low levels mean more.

When you inject testosterone, that feedback arm reads it as an abundance and quiets the pulses down to almost nothing. LH and FSH fall, the Leydig cells lose their instruction to work, and over months on a stable dose they shrink and become less responsive to being asked again.

So the machinery that made your own testosterone is still there. It has just gone quiet because nothing has been asking it to do anything for months or years.

That is the setup for what happens when you stop injecting. You can do it that way, but you're gonna experience a plummet in your testosterone levels, especially if you've been on it for a long time.

The plummet has a specific shape, and it comes down to timing. Testosterone cypionate has a half-life of roughly eight days and enanthate closer to four and a half, so after your last shot the drug is essentially gone from your blood inside three to six weeks. Your pituitary does not come back on that schedule.

You end up in a gap, where the outside supply is gone, the inside supply has not restarted, and for that stretch your total testosterone can sit lower than it was before you ever touched the drug.

Christou and colleagues pooled the available data on this in Sports Medicine in 2017, looking at reproductive hormones in athletes and recreational users across dozens of studies, and the pattern was consistent. During use, LH and FSH were suppressed and sperm parameters were reduced, and after stopping, recovery of the axis happened over months rather than weeks, with wide variation between individuals.

For some men it does not resolve on its own in any reasonable timeframe. Kanayama and colleagues published a paper in Addiction in 2015 on exactly this, describing men who had been off anabolic steroids for a year or more and were still sitting in the hypogonadal range on labs. Their argument was that it goes under-recognized, because the fatigue, the flat mood, and the dead libido get blamed on age, stress, or overtraining instead of on a pituitary that never restarted.

And the crash is not only about how you feel. Yialamas and colleagues, publishing in the Journal of Clinical Endocrinology and Metabolism in 2007, took a small group of men with idiopathic hypogonadotropic hypogonadism, men whose hormone levels are entirely dependent on what they are given, and withdrew their sex steroids for two weeks, and insulin sensitivity measurably dropped in that window.

Two weeks is how quickly the metabolic side of testosterone withdrawal shows up, which is worth holding onto when someone tells you to just tough out a few months of nothing.

Typically the protocol when you're coming off of gear or TRT would be to have a CIRM about four weeks before the end of your cycle.

The class of drug there is a SERM, a selective estrogen receptor modulator, which is a compound that blocks the estrogen receptor in some tissues while acting like estrogen in others. In the hypothalamus and pituitary, blocking that receptor means the feedback arm goes silent, your brain reads it as low estrogen, and it responds the only way it knows how, by speeding the GnRH pulses back up and pushing LH and FSH out.

That is the entire point of using one. You are not adding testosterone from outside, you are removing the brake on the system that makes it.

On the naming, a lot of people say Clomid, Nolvadex, and clomiphene as if they were three separate options, and the instinct behind that is right, because those are the two drugs that get used here. Clomid is the brand name for clomiphene citrate, so those two are the same molecule, and Nolvadex is the brand name for tamoxifen, which is a different SERM that works through the same receptor at the pituitary.

Clomiphene is worth understanding at the molecular level, because it explains why the doses in the protocol below look so small: it is a mixture of two isomers, enclomiphene and zuclomiphene, and they do not behave the same way.

Enclomiphene is the antagonist doing the work at the pituitary, and it clears relatively fast. Zuclomiphene is weakly estrogenic and clears slowly, with elimination measured in weeks rather than days, so it accumulates in your tissue over the course of a course.

Bandura and colleagues reviewed clomiphene citrate specifically as off-label post cycle therapy in Andrology, covering the mechanism, what the efficacy data actually shows, and the diagnostic problems it creates. The accumulating zuclomiphene fraction is part of why higher doses can bring mood changes and visual disturbances, and why a smaller dose held for longer often does the same job to the axis with less noise.

Let's say in Clomiphene as an example, you could do like six, six milligrams, six and a half milligrams for two weeks, move up to 12 and a half milligrams, come off of the testosterone at week four, and then continue with the 12 and a half milligram dose for two to four more weeks.

Practically, a clomiphene tablet is 50 milligrams, so 6.25 is an eighth of a tablet and 12.5 is a quarter. Those are small fractions of what gets thrown around online, and the sequencing is what makes them enough.

The overlap sits in those first two weeks of low-dose SERM, which happen while you are still injecting, meaning the pituitary starts getting nudged back into producing LH and FSH before the outside supply disappears.

Your Leydig cells get an instruction while your blood levels are still held up by the ester in your system. Then testosterone comes out at week four, and by the time the last of it clears three to six weeks later, the pulses have already been running for a month and a half, so the gap gets narrowed instead of ignored.

There is a real limit to how strongly a SERM can push while exogenous testosterone is still on board, because that testosterone is still feeding back on the same tissue you are trying to disinhibit. The low dose in those first two weeks is priming, not a full restart.

And then if you need to, you can increase the 25 milligrams for the last four weeks. That is the escalation for the man whose LH is still on the floor, and the phrase to sit with is if you need to, because a lot of guys do not, and pushing the dose up on principle just buys the side effects without buying more signal.

Which is exactly why you test instead of guessing. I would say get your labs at week eight, and then again at week 12 to kind of see where you stand as you start to taper those doses down.

At week eight you are looking for evidence that the pituitary is participating, so LH and FSH matter more than the testosterone number itself. A total testosterone of 500 with an LH of 0.2 tells you the drug is doing all the work. The same 500 with an LH in the normal range tells you the loop is closing on its own.

Run total and free testosterone, LH, FSH, a sensitive estradiol, and SHBG, and it is worth adding hematocrit if you were on for a long time, since blood thickening from testosterone use takes its own months to normalize.

The week 12 draw is the one that shows direction. Compare it against week eight while the dose is coming down, and you are watching whether the system holds its own output as the support is removed.

This is the diagnostic problem the Bandura review flagged. Clomiphene raises testosterone while you are taking it, which means a good-looking lab drawn mid-protocol can be entirely the drug and tells you almost nothing about your recovered baseline. The honest number comes weeks after the last dose, and rushing to that conclusion is how men end up surprised six months later.

Two more things that change the picture depending on who you are.

If you came to TRT because you were genuinely hypogonadal, post cycle therapy returns you to your own baseline, and your own baseline was low. That is not a failure of the protocol. It is information about why you started, and for some men the reasonable answer after seeing it is to go back on with a doctor rather than chase a level their pituitary never produced.

And if you were running supraphysiologic doses rather than replacement, the recovery timeline stretches with the duration and the dose, and the reason not to simply stay on forever shows up in places like the BMJ Case Reports paper by Choulerton and colleagues, which documented an ischaemic stroke in a young, otherwise healthy fitness enthusiast using anabolic steroids. The vascular cost of staying on is the other side of the ledger you are weighing when you plan how to come off.

What most people picture is a switch that got flipped off and has to be flipped back on, which is why cold turkey feels reasonable and why the crash feels like bad luck, but it works more like a conversation, since your brain stopped asking because you kept answering for it, and the taper works because it puts the question back in the room while the answer is still there, so nobody is ever waiting in silence.

References:

Christou MA, Christou PA, Markozannes G et al.. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis. Sports Med. 2017. https://pubmed.ncbi.nlm.nih.gov/28258581/

Kanayama G, Hudson JI, DeLuca J et al.. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem. Addiction. 2015. https://pubmed.ncbi.nlm.nih.gov/25598171/

Yialamas MA, Dwyer AA, Hanley E et al.. Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2007. https://pubmed.ncbi.nlm.nih.gov/17726076/

Bandura A, Furka S, Hromníková D et al.. Clomiphene Citrate in off-Label Post-Cycle Therapy: Mechanisms, Efficacy and Diagnostic Challenges in Endocrine Recovery Following Anabolic Steroid Use. Andrology. 2026. https://pubmed.ncbi.nlm.nih.gov/42387872/

Choulerton J, Guha N, Squires R. Anabolic steroid use and ischaemic stroke in a young fitness enthusiast. BMJ Case Rep. 2021. https://pubmed.ncbi.nlm.nih.gov/33542023/